Using a modular massively parallel reporter assay to discover context-dependent regulatory activity in type 2 diabetes-linked noncoding regions

Most complex trait association signals reside in the noncoding genome, where defining function is challenging. MPRAs (massively parallel reporter assays) offer a scalable means to test variants' regulatory impacts but are typically cell-type agnostic, pairing cloned fragments with generic "housekeeping" promoters. To explore MPRAs' context sensitivity, we screened a panel of nearly 12,000 fragments across >300 diabetes- and metabolic-trait-associated regions in a pancreatic β cell line model. We compared activity when fragments were placed up- versus downstream of a reporter gene and combined with the synthetic housekeeping promoter super core promoter 1 (SCP1) versus the physiologically relevant human insulin (INS) gene promoter. We identified clear effects of MPRA construct design on regulatory activity. A subset of fragments (n = 702/11,656) displayed positional bias, evenly distributed across up- and downstream preferences. Promoter choice also influenced MPRA activity (n = 698/11,656), mostly biased toward the cell-specific INS promoter (73.4%). A screen for sequence annotations associated with INS promoter preference revealed enrichment for HNF1 binding motifs. HNF1 family transcription factors are key regulators of glucose metabolism disrupted in maturity-onset diabetes of the young (MODY), suggesting genetic convergence between rare coding variants that cause MODY and common type 2 diabetes (T2D)-associated regulatory regions. A follow-up HNF1-focused MPRA highlighted several instances where motif deletion or mutation disrupted regulatory activity specifically in the context of the INS1 promoter and in the β cell model but not in another diabetes-relevant cell type, skeletal muscle. These results identify technical factors that may require careful consideration while designing MPRA experiments.

Authors

Institutions

Publication Details

Journal
Human Genetics and Genomics Advances
Published
2026-04-07
DOI
https://doi.org/10.1016/j.xhgg.2026.100606
Primary Topic
Pancreatic function and diabetes
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Using a modular massively parallel reporter assay to discover context-dependent regulatory activity in type 2 diabetes-linked noncoding regions

Adelaide Tovar, Arushi Varshney, Kirsten Nishino, Yasuhiro Kyono et al.
Human Genetics and Genomics Advances
Pancreatic function and diabetes
article

Using a modular massively parallel reporter assay to discover context-dependent regulatory activity in type 2 diabetes-linked noncoding regions

Adelaide Tovar, Arushi Varshney, Kirsten Nishino, Yasuhiro Kyono, Jacob Otto Kitzman, Maya Bose, Stephen Parker
article en

Abstract

Most complex trait association signals reside in the noncoding genome, where defining function is challenging. MPRAs (massively parallel reporter assays) offer a scalable means to test variants' regulatory impacts but are typically cell-type agnostic, pairing cloned fragments with generic "housekeeping" promoters. To explore MPRAs' context sensitivity, we screened a panel of nearly 12,000 fragments across >300 diabetes- and metabolic-trait-associated regions in a pancreatic β cell line model. We compared activity when fragments were placed up- versus downstream of a reporter gene and combined with the synthetic housekeeping promoter super core promoter 1 (SCP1) versus the physiologically relevant human insulin (INS) gene promoter. We identified clear effects of MPRA construct design on regulatory activity. A subset of fragments (n = 702/11,656) displayed positional bias, evenly distributed across up- and downstream preferences. Promoter choice also influenced MPRA activity (n = 698/11,656), mostly biased toward the cell-specific INS promoter (73.4%). A screen for sequence annotations associated with INS promoter preference revealed enrichment for HNF1 binding motifs. HNF1 family transcription factors are key regulators of glucose metabolism disrupted in maturity-onset diabetes of the young (MODY), suggesting genetic convergence between rare coding variants that cause MODY and common type 2 diabetes (T2D)-associated regulatory regions. A follow-up HNF1-focused MPRA highlighted several instances where motif deletion or mutation disrupted regulatory activity specifically in the context of the INS1 promoter and in the β cell model but not in another diabetes-relevant cell type, skeletal muscle. These results identify technical factors that may require careful consideration while designing MPRA experiments.

Human Genetics and Genomics AdvancesVol. 7(3)
University of Michigan (US)
Burroughs Wellcome Fund, National Human Genome Research Institute, National Institute of General Medical Sciences, National Institute of Diabetes and Digestive and Kidney Diseases
Openalex Percentile: Top 31%
Pancreatic function and diabetes
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.